Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

February 26, 2021

Psychosis in Systemic Lupus Erythematosus (SLE): 40-year experience of a specialist centre.

Esha AbrolDavid Isenberg
February 23, 2021
Case Report
Open Access

Anti-N-Methyl-D-Aspartate Receptor Encephalitis with Decrease in Blood Flow in Cerebellum.

Case Reports in Neurology
Koji ObaraItaru Toyoshima
February 23, 2021
Open Access

Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis.

Frontiers in Neurology
Lulu YanJun Wu
February 23, 2021

Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis.

Seizure : the Journal of the British Epilepsy Association
Maria Ilyas-FeldmannMartin Holtkamp
February 21, 2021
Open Access

Clinical efficacy of plasma exchange in patients with autoimmune encephalitis.

Annals of Clinical and Translational Neurology
Yan ZhangYing-Ying Su
February 17, 2021

Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China.

Neurology. Neuroimmunology and Neuroinflammation
Xue GongZhen Hong
February 16, 2021

Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis.

Journal of Neuroimmunology
James BroadleyAustralian Autoimmune Encephalitis Consortium
February 12, 2021

Catatonia in the medically ill: Differences and parallels in etiology, phenomenology and management.

International Journal of Psychiatry in Medicine
Fernando Espi ForcenCharles Hebert
February 9, 2021
Open Access

Autoimmune Encephalitis in Latin America: A Critical Review.

Frontiers in Neurology
Gabriel de Albuquerque VasconcelosPedro Braga-Neto
February 7, 2021

Bortezomib for treatment of anti-NMDA receptor encephalitis in a pediatric patient refractory to conventional therapy.

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Marroyln L Simmons, Kimberly A Perez
February 5, 2021
Open Access

Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis.

Biological Psychiatry
Thomas A PollakPhilip McGuire
February 4, 2021
Open Access

A 24-year-old female with anti-N-methyl-D-aspartate receptor encephalitis: a case report

Antoine SteemanGuy Mazairac
February 3, 2021

Encephalitis in Previously Healthy Children.

Pediatrics in Review
Claire E FraleyDawn Nolt
January 30, 2021

Mature ovarian teratoma associated with anti-N-Methyl-D-aspartate receptor encephalitis: A case report.

The Medical Journal of Malaysia
I N B MahendraN P Ekawati

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

© 2021 Meta ULC. All rights reserved